HER2阳性胆囊癌的影像学特征:CT特征分析
本研究纳入213例病理确诊且HER2状态可用的胆囊癌患者(171例HER2阴性,42例HER2阳性),由两名对HER2状态不知情的放射科医生评估治疗前增强CT。多因素分析显示淋巴结压迫胆管是HER2阳性的最强正向预测因子(OR 2.99),动脉期高强化、结石存在和肿块样形态为显著负向预测因子,模型AUC 0.782,敏感度75%,特异度79.4%,阴性预测值96.2%。
要点
- 淋巴结压迫胆管是HER2阳性的最强正向预测因子(OR 2.99,95%CI 1.25-7.04)。
- 动脉期高强化、结石存在和肿块样形态为HER2阳性的显著负向预测因子。
- 模型AUC 0.782,敏感度75%,特异度79.4%,阴性预测值96.2%。
核心结论
- HER2阳性胆囊癌具有特征性CT表现,可用于无创诊断且预测性能良好。
研究设计与样本
- 本研究为回顾性分析,纳入213例病理确诊且HER2状态可用的胆囊癌患者(171例HER2阴性,42例HER2阳性),评估治疗前增强CT,由两名对HER2状态不知情的放射科医生阅片,采用L2正则化逻辑回归多因素分析,ROC分析评估模型区分度,bootstrap重采样(1000次迭代)进行内部验证以校正乐观偏倚。
关键影像表现/征象
- HER2阳性组淋巴结较大(1.93 ± 0.79 cm vs. 1.61 ± 0.61 cm,p = 0.015)。
- HER2阳性组结石出现频率较低(14.3% vs. 35.7%,p = 0.013)。
- HER2阳性组动脉期高强化出现频率较低(20.0% vs. 44.1%,p = 0.026)。
- HER2阳性组肿块样形态出现频率较低(35.7% vs. 55.6%,p = 0.033)。
- HER2阳性组淋巴结压迫胆管出现频率较高(19.0% vs. 4.1%,p = 0.002)。
诊断标准与关键数值
- 多因素分析显示淋巴结压迫胆管为HER2阳性的最强正向预测因子(OR 2.99,95%CI 1.25-7.04)。
- 动脉期高强化为HER2阳性的显著负向预测因子(OR 0.40,95%CI 0.19-0.75)。
- 结石存在为HER2阳性的显著负向预测因子(OR 0.40,95%CI 0.18-0.75)。
- 肿块样形态为HER2阳性的显著负向预测因子(OR 0.54,95%CI 0.29-0.95)。
- 模型区分度AUC 0.782,敏感度75%,特异度79.4%,阴性预测值96.2%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to identify distinctive computed tomography (CT) features associated with human epidermal growth factor receptor 2 (HER2) status in gallbladder cancer (GBC) that could serve as noninvasive imaging biomarkers.
MATERIALS AND METHODS: This study included 213 patients with pathologically confirmed GBCs with availability of HER2 status (171 HER2-negative, 42 HER2-positive). Pre-treatment contrast-enhanced CT scans were evaluated by two radiologists blinded to HER2 status. Multivariate analysis was performed using logistic regression with L2 regularization. Model discrimination was assessed using receiver operating characteristic (ROC) analysis, and internal validation was performed using bootstrap resampling (1,000 iterations) to correct for optimism.
RESULTS: HER2-positive tumors exhibited larger lymph nodes (1.93 ± 0.79 cm vs. 1.61 ± 0.61 cm, p = 0.015), less frequent gallstones (14.3% vs. 35.7%, p = 0.013), arterial phase hyperenhancement (20.0% vs. 44.1%, p = 0.026), mass-like morphology (35.7% vs. 55.6%, p = 0.033), and more frequent biliary compression by lymph nodes (19.0% vs. 4.1%, p = 0.002). Multivariate analysis identified biliary compression by lymph nodes as the strongest positive predictor of HER2 positivity [odds ratio (OR) 2.99, 95% CI: 1.25-7.04], while arterial phase hyperenhancement (OR 0.40, 95% CI: 0.19-0.75), gallstone presence (OR 0.40, 95% CI: 0.18-0.75), and mass-like morphology (OR 0.54, 95% CI: 0.29-0.95) were significant negative predictors. The model demonstrated good discrimination (area under the ROC curve 0.782) with sensitivity 75%, specificity 79.4%, and negative predictive value 96.2%.
CONCLUSION: HER2-positive GBCs display characteristic CT findings that can be utilized for noninvasive diagnosis with robust predictive performance.
引用
- Gupta P, Dutta N, Singh S, et al. Radiological signature of HER2-Positive gallbladder cancer: analysis of CT features. Abdom Radiol (NY). 2025. PMID: 40603735. doi:10.1007/s00261-025-05087-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。